75,000 Shares in Oscar Health, Inc. (NYSE:OSCR) Bought by Toronto Dominion Bank

Toronto Dominion Bank purchased a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 75,000 shares of the company's stock, valued at approximately $1,008,000.

Other large investors have also recently bought and sold shares of the company. Southeastern Asset Management Inc. TN boosted its stake in Oscar Health by 52.2% during the 4th quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock worth $42,082,000 after purchasing an additional 1,073,359 shares during the period. Jacobs Levy Equity Management Inc. lifted its stake in shares of Oscar Health by 37.8% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company's stock worth $23,403,000 after acquiring an additional 477,634 shares during the period. Man Group plc lifted its stake in shares of Oscar Health by 344.8% in the 4th quarter. Man Group plc now owns 1,813,216 shares of the company's stock worth $24,370,000 after acquiring an additional 1,405,554 shares during the period. Lingotto Investment Management LLP acquired a new stake in shares of Oscar Health in the 4th quarter worth $2,543,000. Finally, GDS Wealth Management lifted its stake in shares of Oscar Health by 1,545.3% in the 4th quarter. GDS Wealth Management now owns 345,817 shares of the company's stock worth $4,648,000 after acquiring an additional 324,798 shares during the period. Institutional investors and hedge funds own 75.70% of the company's stock.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. Wall Street Zen upgraded shares of Oscar Health from a "hold" rating to a "buy" rating in a research note on Saturday. Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their target price for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $18.50.

Oscar Health Price Performance

Shares of NYSE OSCR traded down $0.13 during midday trading on Wednesday, hitting $14.12. The company had a trading volume of 8,375,870 shares, compared to its average volume of 4,488,081. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a twelve month low of $11.20 and a twelve month high of $23.79. The business has a 50-day simple moving average of $13.78 and a two-hundred day simple moving average of $14.58. The firm has a market capitalization of $3.60 billion, a price-to-earnings ratio of -705.65 and a beta of 1.73.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.83 by $0.09. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The firm had revenue of $3 billion during the quarter, compared to analysts' expectations of $2.87 billion. During the same quarter last year, the business earned $0.62 earnings per share. The business's revenue for the quarter was up 42.2% compared to the same quarter last year. Equities research analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Insider Buying and Selling at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the sale, the director now directly owns 64,512 shares of the company's stock, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 24.39% of the stock is currently owned by insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.